Prevenar13 ( DrugBank: - )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	1
265	脂肪萎縮症	1

19. ライソゾーム病

---

臨床試験数 : 854 /  薬物数 : 716 - (DrugBank : 105) / 標的遺伝子数 : 70 - 標的パスウェイ数 : 191

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-004846-25-BE (EUCTR)	15/07/2016	30/03/2016	Anti-oxLDL IgM antibodies as a novel therapy for metabolic lipid diseases	Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders	Familial hypercholesterolemia Niemann-Pick disease type B (NPB)Niemann-Pick disease type C (NPC)Partial lipodystrophy in children and adults;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Trade Name: Prevenar13 Product Name: Prevenar13	Maastricht University	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Belgium

265. 脂肪萎縮症

---

臨床試験数 : 116 /  薬物数 : 170 - (DrugBank : 61) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 97

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-004846-25-BE (EUCTR)	15/07/2016	30/03/2016	Anti-oxLDL IgM antibodies as a novel therapy for metabolic lipid diseases	Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders	Familial hypercholesterolemia Niemann-Pick disease type B (NPB)Niemann-Pick disease type C (NPC)Partial lipodystrophy in children and adults;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Trade Name: Prevenar13 Product Name: Prevenar13	Maastricht University	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Belgium